LFST Stock Recent News
LFST LATEST HEADLINES
Director William Miller to Step Down SCOTTSDALE, Ariz. , Aug. 22, 2025 /PRNewswire/ -- LifeStance Health (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced the appointment of Sarah Personette, an accomplished customer experience, media and technology executive, to the company's board of directors, effective today.
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants David Patrick Bourdon - CEO & Director Monica Prokocki - Vice President of Investor Relations Ryan Bruce McGroarty - CFO & Treasurer Conference Call Participants Brian Gil Tanquilut - Jefferies LLC, Research Division Craig Matthew Hettenbach - Morgan Stanley, Research Division David Michael Larsen - BTIG, LLC, Research Division Jamie Aaron Perse - Goldman Sachs Group, Inc., Research Division Kevin Caliendo - UBS Investment Bank, Research Division Lisa Christine Gill - JPMorgan Chase & Co, Research Division Matthew Mardula - Unidentified Company Richard Collamer Close - Canaccord Genuity Corp., Research Division Steven Craig Dechert - KeyBanc Capital Markets Inc., Research Division Operator Hello, and welcome to the LifeStance Health Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Now I would like to turn the call over to Monica Prokocki.
LifeStance Health Group (LFST) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.06 per share a year ago.
SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2025.
LifeStance Survey Finds Money Stress Significantly Impacts Americans' Mental Health and Ability to Seek Care SCOTTSDALE, Ariz. , July 22, 2025 /PRNewswire/ -- A LifeStance Health survey released today reveals "stressflation" is affecting most Americans, with 83% reporting financial stress driven by inflation, mass layoffs, the rising cost of living and recession fears.
SCOTTSDALE, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2025 earnings release before the market opens on Thursday, August 7, 2025.
CSW, ASAN, and others show rising P/E trends -- suggesting breakout potential backed by strong earnings surprises.
LifeStance Health is showing a real turnaround, posting its first-ever net profit and rapidly expanding margins, signaling operational discipline and scalable growth. The company's hybrid care model positions it well amid surging mental health demand, with strong revenue and clinician growth supporting its bullish outlook. Despite a mixed valuation and recent insider selling, institutional investors are accumulating shares, reflecting confidence in LifeStance's long-term margin expansion and platform potential.
LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.